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Johrei Family Healing: A Pilot Study
P. H. Canter, L. B. Brown, C. Greaves and E. Ernst
Peninsula Medical School, Universities of Exeter and Plymouth, UK
Johrei is a form of spiritual healing comprising ‘‘energy channelling’’ and light massage given either
by a trained healer or, after some basic training, by anyone. This pilot trial aimed to identify any
potential benefits of family-based Johrei practice in childhood eczema and for general health and to
establish the feasibility of a subsequent randomised controlled trial. Volunteer families of 3-5
individuals, including at least one child with eczema were recruited to an uncontrolled pilot trial
lasting 12 months. Parents were trained in Johrei healing and then practised at home with their family.
Participants kept diaries and provided questionnaire data at baseline, 3,6 and 12 months. Eczema
symptoms were scored at the same intervals. Scepticism about Johrei is presently an obstacle to
recruitment and retention of a representative sample in a clinical trial, and to its potential use in
general practice. The frequency and quality of practise at home by families may be insufficient to
bring about the putative health benefits. Initial improvements in eczema symptoms and diary recorded
illness, could not be separated from seasonal factors and other potential confounders. There were no
improvements on other outcomes measuring general health and psychological wellbeing of family
members.
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Introduction
Johrei is a Form of Spiritual Healing
Johrei healing, originated in Japan, is a form of spiritual
healing comprising ‘energy channelling’ and light massage.
The latter incorporates elements of Reiki and acupressure.
Energy channelling is the direction of an intangible healing
energy through the hands of the healer at a distance from the
person receiving healing. Practitioners differ in the emphasis
given to these two components. Johrei can be learned and
practised by anyone and is seen as a two-way process that heals
both the healer and the person healed.
Johrei is practised within some Japanese families and,
anecdotally, such families are healthier and use less medica-
tion than those who do not practise Johrei. Anecdotal evidence
also supports its use as a treatment for childhood eczema.
Scientific evidence is limited and variable in quality. Naito (1)
suggests a beneficial effect on stress and the immune system.
Taft (2) contradicts claims that Johrei has a beneficial effect on
cell death and proliferation rates of cultured human cancer
cells. Johrei healing is not widely practised in the UK at
present but some doctors do advocate its use arguing that it
could produce general health benefits and save money for
the NHS.
Why We Have Carried Out This Study
Here, we describe a pilot study designed to explore the
acceptability of Johrei healing in the UK, identify any
recruitment, compliance and retention problems, identify
potential health benefits including those for childhood eczema,
identify suitable outcome measures, estimate effect sizes, and
establish the feasibility of a subsequent randomized clinical
trial (RCT). The effects of Johrei on childhood eczema
specifically as well as upon general family health were
considered because of favorable anecdotal reports in this
condition, and because it was thought desirable to include at
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assessed using a standardized symptom score. A year-long
pilot study was initiated because practitioners insisted that the
benefits of Johrei would only manifest with long-term, regular
practice. If this is the case then the issues of retention and
long-term compliance are also important in assessing the
practical application of Johrei self-healing as a health care
strategy.
Method
Trial Design, Funding and Ethics Approval
The study was a prospective, single-center, uncontrolled pilot
trial with a 12 month treatment period. The study was funded
by Sekai Kyusei Kyo Izunome through the British Johrei
Society. The protocol was developed in discussion with the
sponsors and approved by the North and East Devon Local
Research Ethics Committee.
How we Recruited Families and Inclusion Criteria
Recruitment of volunteer families began in March 2003
through press releases and advertising in local General
Practice (GP) surgeries. GP surgeries are primary care facilit-
ies provided throughout the UK as part of the National Health
Service. We aimed to recruit 20 families, a number which we
regarded as achievable within the 2 year time-frame of the
study’s funding and practical in terms of the logistics and
resources available for initial training in Johrei and follow-up
sessions. Inclusion criteria were as follows: (i) Families had
to comprise 3–5 individuals living under one roof. (ii)
Families had to include at least one child with diagnosed
atopic eczema. (iii) Families had to live within 15 miles (later
extended to 30 miles) of the study center in Exeter where
training sessions were held. (iv) All family members, old
enough to do so, had to agree to participate in the trial by
learning and practicing Johrei and completing the outcome
measures. All family members were required to learn and
practice Johrei because it is a mutual process in which one
member heals another and practitioners insist that maximum
benefits for family health are enjoyed when the whole family
participates.
How Families Learned and Practised Johrei
Representatives from each family were required to attend three
group meetings led by a trained Johrei teacher to learn the
healing techniques. They were then asked to practise with
other family members at home on a regular basis. Families
were encouraged to attend monthly group follow-on sessions
with the Johrei teacher to review the healing procedure and
discuss their experiences. Groups of families were trained
in three cohorts and follow-on sessions involved families from
all three cohorts.
We Measured Health, Well-being and Eczema
Symptoms every 3 Months
General health and psychological well-being were assessed at
baseline, 3, 6, 9 and 12 months using the validated quality of
life questionnaires WHOQOL-BREF (3) and SF-36 (4), the
Significant Others Scale (SOS) (5), a measure of social support
and the Perceived Stress Scale (PSS) (6). Eczema symptoms
were assessed by physically examining the child every
3 months using a validated clinical assessment procedure, the
Six Area Six Sign Atopic Dermatitis (SASSAD) score (7) and
an eczema-specific questionnaire, the Childrens Dermatology
Life Quality Index (CDLQI) (8). The SASSAD scoring was
carried out by a Research Assistant trained in its use. Six signs
of eczema (erythema, lichenification, excoriation, dryness,
cracking and exudation) were scored by physical examination
of six areas of the body (head and neck, hands, arms, trunk,
feet, and legs). The SASSAD score is the total score for
all signs in all areas. The maximum score, corresponding to
the most severe eczema, is 108. The CDLQI is a validated
questionnaire for children aged 5–16. It comprises 10 ques-
tions about the degree to which the child’s skin problems have
affected various aspects of their daily life including discom-
fort/pain, embarrassment, friendships, clothing choices, play,
sports, schoolwork, teasing/bullying, sleep and treatment.
Each answer is scored from 0 to 3 with 3 indicating more of
a problem and a maximum score of 30 representing the biggest
interference with daily life. Families also kept diaries
recording periods of illness, days off work or school and
regularity of Johrei practise. Families completing the 12 month
trial were interviewed following a structured procedure and
medical records were accessed for the year preceeding the trial
and the year of the trial itself. The Research Assistant kept in
regular telephone contact with all families, reminding them
to attend training sessions and monthly follow-on sessions and
to return diary data and completed questionnaires. Particular
attempts were made to contact and encourage families who
appeared to be on the point of dropping out or who were not
returning data.
Results
Recruitment, Retention and Compliance were all
Problematic
Despite several press releases, newspaper advertisements,
advertising in GP surgeries and an increase of the initial
catchment area from a 15 mile radius around Exeter to a
30 mile radius, recruitment proved difficult. After 12 months
there were a total of 94 telephone and e-mail enquiries from
potential recruit families. Telephone interviews established
that 29 of these 94 families did not meet the inclusion criteria.
After receiving detailed written information about Johrei, the
teaching protocol and what was involved in the trial, 46 of the
remaining 65 families decided not to participate and 2 families
could not be contacted again.
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refused (n ¼ 9), other family members refused (n ¼ 4), time
commitment too great or conflict with husband/wife’s
work pattern (n ¼ 11), family member ill or going into hospital
(n ¼ 2), planning overseas trip (n ¼ 1), Exeter too far to travel
forJohreitraining(n¼1),advisedbyhospitalnottoparticipate
(n ¼ 1), family member not wanting to be touched or massaged
(n ¼ 2), opted to take part in another trial (n ¼ 1), not happy
with medical records being accessed (n ¼ 1), legal guardian of
child would not consent (n ¼ 1), no specific reason given
(n ¼ 4) and failed to respond to follow-on contacts (n ¼ 8).
The outcome for the 17 families who gave written consent to
participate in the trial is shown in Table 1.
Diary estimates showed that for the nine families who
completed training and stayed in the trial for at least 3 months,
the mean number of healing sessions was 1.8 per week. Table 2
shows the range, mean and standard deviations for number of
practise sessions per individual per week in each month of the
trial. Overall, the mean number of sessions shows no trend to
increase or decrease over the course of the trial. Subgroup
analysis revealed that the mean number of Johrei sessions per
week was 2.3 for mothers, 1.0 for fathers, 2.1 for children with
eczema and 1.6 for children without eczema.
Evidence for General Health Benefits was Limited
The family diaries indicated no obvious trend towards an
increase or decrease in GP visits or use of complementary or
alternative medicine practitioners during the period of the trial.
Figure 1 shows that the mean number of days ill reported by
families declined during the study. Data are presented
separately for the nine families who completed training in
Johrei and for the subgroup of four families who completed the
full 12 month trial (completers). It should be noted that six of
the nine families belonged to the second and third cohorts who
began training in October and November. The remaining three
families began training in June and only one of these was still
enrolled in the trial beyond 3 months. The data for the second
half of the trial are, therefore, almost entirely summer data.
Illness sufficiently serious to cause days off work or school,
showed no clear trend to increase or decrease over the course
of the trial. There were 9 days of illness requiring hospital
treatment among all nine families in the 12 month period and
no particular trend was evident in the data.
Eczema Symptoms Improved Initially in some Children
but this may be due to Seasonal or Other Factors
A total of 18 children diagnosed with eczema were enrolled in
the trial and baseline data were obtained for 15 children. There
were 10 children with eczema in the 9 families who completed
Johrei training. As shown in Fig. 2, the mean SASSAD scores
fell between baseline and 3 months and then rose again
between 9 and 12 months. The individual data (Fig. 3) shows
that the rise in mean eczema severity between months 6 and 12
is largely due to the deterioration in symptoms of one child.
For these 10 children, the change in total SASSAD score
from baseline to 3 months and the number of Johrei sessions
reported for that child during the first 3 months were not
correlated at a statistically significant level (Pearson r ¼ 0.379,
P ¼ 0.28). The correlation between change in total SASSAD
score from baseline to 3 months and number of sessions per
family, adjusted for number of people in the family, during the
first 3 months was higher but still did not reach statistical
significance (Pearson r ¼ 0.474, P ¼ 0.166).
The CDLQI was administered at baseline to the five children
in the study who met the age qualification stipulated. These
five children came from five different families but only three
of these families completed the training. Figure 4 indicates a
short-term fall in the mean CDLQI score at 3 months for these
three children.
Quality of Life Measures showed No Improvements
When scores were analyzed for either all families completing
training (n ¼ 9) or for those families completing the trial
Table 1. Consenting families
n Outcome Reasons given for withdrawal
4 Failed to attend Johrei
training
Separation (n ¼ 1), illness
(n ¼ 1), illness and husband
changed his mind (n ¼ 1),
no reason given (n ¼ 1)
4 Withdrew after second
training session
Moved house (n ¼ 1), time
comittment too great (n ¼ 1)
no reason given (n ¼ 2)
3 Dropped out at 3 months Emigrated (n ¼ 1), could not
fit Johrei into routine (n ¼ 1),
husband lost interest (n ¼ 1)
1 Dropped out at 6 months Pressure of work (n ¼ 1)
1 Dropped out at 9 months No reason given (n ¼ 1)
4 Completed 12 month trial n/a
Table 2. Diary estimates of mean number of Johrei sessions per
individual, per week
Month Families
with data
Individuals
with data
Min Max Mean SD
1 8 31 0 6 2.2 1.8
2 9 35 0 7 2.1 2.1
3 7 35 0 5 1.6 1.9
4 7 27 0 6 1.8 1.8
5 6 23 0 6 1.7 1.9
6 5 19 0 6 1.6 2.1
7 6 23 0 6 1.8 2.1
8 5 19 0 6 1.9 2.3
9 4 16 0 6 2.3 2.3
10 3 11 0 6 2.3 2.1
11 4 15 0 5 1.4 1.6
12 3 11 0 5 2.0 1.9
Overall 9 35 0 7 1.8 1.5
eCAM 2006;3(4) 535(n ¼ 4) there were no signs of improvement or deterioration in
scores on the SF-36, WHOQUOL-BREF, SOS or PSS.
Medical Records Indicated No Improvements
For the four families who completed the trial, GP records were
compared for the 12 months preceeding entry to the trial
and for the 12 month period of the trial. Number of con-
sultations, number of recorded illnesses, number of prescribed
medicines and number of certified days off school or work
were recorded for each period. Figure 5 shows that there were
slightly more consultations, recorded illnesses and prescribed
medicines during the year of the trial than during the
preceeding year.
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Figure 1. Mean number of days ill per family, per month, as reported in diaries.
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Figure 2. Eczema severity as measured by clinical examination (mean SASSAD score).
536 Johrei family healing: a pilot studyMost Families were Sceptical in Final Interviews
SemistructuredinterviewsconductedbytheResearchAssistant
at the homes of the four families completing the trial were
recorded and transcribed. The main themes to emerge were (i)
families enrolled in the trial to seek help for their child’s
eczema. Even though some of them were sceptical or
suspicious, they were willing to try anything; (ii) families
were pleased with the way Johrei training sessions were
conducted except that several were concerned about a change
of teachers part way through the trial. Some felt consistency
and developing a relationship with the teacher was important;
several families mentioned changes in style between hands-on
and hands-off healing between teachers; (iii) healing was
usually centered around the mother and was most usually
practised by the mother on the child with eczema; (iv) several
families thought their child’s eczema may have improved
somewhat during the trial but they were reluctant to attribute
improvement to Johrei and mentioned growing out of it,
changes in medication and other factors which may have
been important; (v) similarly, two families noticed changes
in how relaxed or well they felt generally but mentioned
other factors such as exercising more or changes in their
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Figure 3. Eczema severity as measured by clinical examination (mean SASSAD score) for individual children.
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Figure 4. Mean CDLQI score in children aged 5–16 with eczema.
eCAM 2006;3(4) 537diet. There were no negative effects noticed by any of the
families; (vi) attitudes towards Johrei did not change
markedly. Initially sceptical fathers remained sceptical;
(vii) at least one member of each family said that they
would like to continue to practise Johrei but were not
certain they would actually do so without some support;
(viii) traveling to the training sessions and getting babysit-
ters so that both adults could attend training and follow-on
sessions was a problem for at least one family; (ix) most
families thought it would be better to receive healing from a
trained and qualified practitioner; (x) families were happy
with the questionnaires, diaries and eczema examinations
which were required as part of the trial protocol.
Discussion
This pilot study has used diverse outcome measures in the
form of diary records, questionnaires, clinical examination,
semistructured interview and data extracted from GP records.
As an uncontrolled pilot study it was designed to identify any
trends in data which could feasibly be attributed to the
intervention in order to inform the design of a future RCT.
Is Johrei Effective?
It is not possible to conclude that Johrei healing is either
effective or ineffective from this data, as there are several
alternative explanations for the pattern of data observed. In
particular, the lack of a control group means that any trends
observed should be interpreted with great caution. For
example, the incidence of illness reported in the family
diaries declined, but these data are influenced by the fact that
most families started the trial in the autumn or winter months
when we would expect illnesses to occur more frequently. It
is also inconsistent with the data from GP medical records of
the four families completing the trial. Eczema severity
appeared to fall during the first 3 months of the trial but
again there may be a seasonal effect with symptoms
improving during what was for most children enrolled in
the trial, the winter months at the start of the trial. Some
studies report increased symptom severity associated with the
release of pollen during spring (10) while others report worse
symptoms in winter associated with low sun exposure and
low temperature (11). A specific effect of Johrei on eczema is
difficult to reconcile with the fact that several families
dropped out at 3 months despite this apparent improvement.
Even among the families who completed the trial, most were
reluctant to say unequivocally that there had been a marked
effect on their child’s eczema, or that any effect seen was due
to Johrei. An optimistic interpretation would be that the
improvement in symptoms during the first 3 months led to
the withdrawals at this stage but this is not mentioned among
the reasons given for withdrawing (Table 1). Correlation
coefficients describing the relationship between number of
Johrei sessions in the first 3 months and change in eczema
symptom scores were not statistically significant when
considering either practise sessions specifically with the child
or those practised by the whole family. These correlation
coefficients suggest that only between 0.14 and 0.22 of the
variance (r
2) is accounted for by the differences in level of
practise. The CDQLI data available for three children also
showed an improvement during the first 3 months but this
observation is subject to the same reservations arising from
the lack of a control group. Furthermore, any inferences made
on the basis of data obtained from such an extremely small
sample size are highly unreliable.
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Figure 5. Mean number of GP consultations, recorded illnesses, prescribed medicines and doctor-certified days off work or school, per individual for completers.
538 Johrei family healing: a pilot studyFeasibility of a Future Randomized Clinical Trial
Despite our best efforts, recruitment to this trial was difficult.
There were two main reasons for this. Either a family member,
usually the husband, did not find the idea of Johrei acceptable or
the time commitment required to learn and practice Johrei on a
regular basis was too great. It appears that Johrei healing is not
easily acceptable in the UK. The idea of spiritual healing arouses
scepticism and suspicion, particularly among men. The main
reason that families agreed to participate was because they were
desperate to try anything which might help their child’s eczema.
Families frequently cited the husband’s work schedule as being
incompatible with regular practice of Johrei. Of the 94 original
enquiries,90camefromthemotherofthefamilyandonly4from
the father. It was mainly women who attended the training
sessions. We conclude from this, and from data on who practised
most, that, in the UK, Johrei is more acceptable to women and
that women are more likely to practise it in the home. Any future
researchshouldconsiderhowcrucialfamilyparticipationistothe
practise of Johrei. There are several implications of this
recruitment problem for any future research into Johrei. Even a
large-scale clinical trial, if it encountered similar reticence, but
continued long enough or recruited widely enough to achieve a
sufficiently large sample, would risk ending up with a highly
selected sample. The generalizability of results from such a trial
would be questionable. It would be criticized for recruiting a
specialized population favorably predisposed towards Johrei, for
whom expectations of benefit and likely placebo response might
be considered particularly high.
Of the 17 families who consented to join the trial, 13
attended any of the training sessions, 9 completed the training
and only 4 stayed in the trial for the full 12 months. This
retention problem, if repeated in any future controlled trial,
would further limit the generalizability of its findings. High
drop-out rates are not uncommon in trials of interventions
requiring self-motivation and regular practise as for example
in trials of meditation (9) and may compromise the random-
ization process by introducing systematic differences between
experimental and control groups during the course of the trial.
Having childhood eczema as one of the inclusion criteria
restricted the pool of families from which to recruit and
a research focus on the general health effects of the
intervention might improve recruitment prospects. However,
it was concern about the child’s eczema which brought
families into the study despite initial scepticism. Recruitment
might also be helped by asking people to commit to a shorter
trial. Several families in the trial stated that they would prefer
to receive healing from a qualified practitioner, instead of, or
in addition to the family healing, and this may have made the
trial more attractive to prospective recruits. It would also have
made the intervention more standardized.
Did Families Practise Johrei Enough to Enjoy the
Putative Benefits?
Most families who stayed in the trial continued to practise
throughout with a fairly constant regularity. Whether two
sessions per individual per week on average is sufficient for
any expected benefits to manifest themselves is a moot point.
However, it is clearly the level which we can realistically
expect from the average family asked to practise Johrei at
home—if benefits do not manifest themselves at this level of
practice, then it is not an effective health strategy in practice.
For some families at least, it became apparent that the length of
sessions was highly variable and was sometimes just a few
minutes at a time.
What Would be a Suitable Control Procedure for
Johrei?
The most difficult aspect of designing an RCT to test Johrei
will be to choose an adequate control procedure. It should be
possible to blind subjects as to whether they are receiving
Johrei or a control procedure. In part this depends upon what
is considered to be the essential and characteristic component
of Johrei healing. If it is the healer’s intention to heal and the
putative energy transmitted during the channelling procedure,
then a control procedure involving only touch delivered by
actors or sham healers (12) could be used. If a specific type
of touching is an essential part of Johrei, an adequate control
could be non-specific touch or a specifically different type of
touch. There needs to be similar time spent with individuals
or in groups, similar opportunities for feedback and
discussion of the health issues being researched and
measures taken by those conducting the control procedure
to create the feeling that a real and plausible intervention is
being made.
Conclusions
People in the UK, particularly men, are sceptical about
Johrei healing. It is presently not generally an acceptable
form of treatment and scepticism about Johrei is presently
an obstacle to recruitment and retention of a representative
sample in a clinical trial, and to its potential use in GP.
The frequency and quality of practise at home by families
may be insufficient to bring about the health benefits
claimed for regular Johrei practise. Only 17 of the 65
families who expressed an initial interest in the trial and
were eligible for inclusion were actually persuaded to
enroll, and of these only 9 families completed the training
and the first 3 months of the trial. While children in seven
of these nine families apparently experienced improvement
in their eczema symptoms, seasonal changes and other
potential confounders mean that these changes cannot be
attributed with any confidence to the practice of Johrei.
From the four families who participated in the trial for the
full 12 months, only one child showed a consistent
improvement in eczema symptoms while for another early
improvement was lost in the second 6 months of the trial.
Convincing evidence for a positive effect on general family
health was also lacking.
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